Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Other2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT06097793Early Phase 1Unknown
KSD-101 Therapy for EBV-associated Nasopharyngeal Carcinoma: an Exploratory Clinical Trial
Nasopharyngeal Carcinoma
PrincipalinvestigatorStart date: 2023-12-04
NCT04297995Phase 2Unknown
Evaluate the Efficacy and Safety of HLX10 in Combination With HLX07 in Patients With Advanced Head and Neck Tumors
Head and Neck Squamous Cell Carcinoma
PrincipalinvestigatorStart date: 2020-07-29

Research Network

Collaboration Network

8 collaborators·22 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Tongji Hospital

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Charalampos Floudas, M.D.

National Cancer Institute (NCI)

Moderately Similar
9 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and NeckNasopharyngeal Carcinoma
Similarity Score30%

Nancy Lee, MD

Memorial Sloan Kettering Cancer Center

Moderately Similar
18 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and NeckNasopharyngeal Carcinoma
Similarity Score30%

Ye Guo, MD

Fudan University

Moderately Similar
13 trials

Shared therapeutic areas:

Nasopharyngeal CarcinomaSquamous Cell Carcinoma of Head and Neck
Similarity Score30%

Lizhi Niu, PhD

Fuda Cancer Hospital

Related
31 trials

Shared therapeutic areas:

Nasopharyngeal Carcinoma
Similarity Score15%

Xiaozhong Chen, MD

Zhejiang Cancer Hospital

Related
7 trials

Shared therapeutic areas:

Nasopharyngeal Carcinoma
Similarity Score15%

Vincent Chung

City of Hope Medical Center

Related
9 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and Neck
Similarity Score15%

Yifan Zhai, MD, PhD

Ascentage Pharma Group Inc.

Related
14 trials

Shared therapeutic areas:

Nasopharyngeal Carcinoma
Similarity Score15%

Nina Bhardwaj, MD, PhD

Icahn School of Medicine at Mount Sinai

Related
8 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and Neck
Similarity Score15%

Nieto Luis, Master

Site Coordinator of United Medical Group located in Miami

Related
37 trials

Shared therapeutic areas:

Nasopharyngeal Carcinoma
Similarity Score15%

Jared Weiss, MD

University of North Carolina, Chapel Hill

Related
7 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and Neck
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT06097793Early Phase 1PrincipalInvestigator

KSD-101 Therapy for EBV-associated Nasopharyngeal Carcinoma: an Exploratory Clinical Trial

Nasopharyngeal Carcinoma
Unknown
NCT04297995Phase 2PrincipalInvestigator

Evaluate the Efficacy and Safety of HLX10 in Combination With HLX07 in Patients With Advanced Head and Neck Tumors

Head and Neck Squamous Cell Carcinoma
Unknown

All 2 trials loaded